Abstract
Depression is the most common mental disorder and involves many factors. The regulatory effects of magnesium on N-methyl-D-aspartate (NMDA) channels make it a factor in the treatment of depression. The present study investigated the level of serum magnesium in subjects diagnosed with depression in the city of Yazd in Iran. This cross-sectional study was done from January 2013 to January 2014 on 650 patients with depression who agreed to participate in this study. Diagnosis was made using the Beck Depression Inventory test (BDI-II); those scoring higher than 11 were sent to the medical school laboratory for further testing of serum magnesium levels. The mean age of the patients was 34.16 ± 9.12 years. Of the 650 subjects, 195 were male (30 %) and 455 were female (70 %). The total mean serum magnesium was 2.1 ± 0.26 mg/dl. The prevalence of hypomagnesemia 13.7 %, hypermagnesemia 8.3 %, and sub-optimal magnesium levels was 26.5 %. Sub-optimal prevalence in women (28.1 %) was higher than in men (26.2 %). A significant relationship was observed between depression and serum magnesium level (p = 0.02). The results indicated that the prevalence of hypomagnesemia in subjects diagnosed with depression is high compared to non-depressed individuals. Moreover, there was a significant relationship between hypomagnesemia and intensity of depression that suggests a role for this element in the pathogenesis of the disorder. The high sub-optimal prevalence among women indicates that increased attention should be paid to this group.
Similar content being viewed by others
References
Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S (2013) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2197–2223
Organization WH (2002) Annex 3: burden of disease in DALYs by cause, sex and mortality stratum in WHO regions, estimates for 2001. The world health report 2002:192–197
Van de Velde S, Bracke P, Levecque K (2010) Gender differences in depression in 23 European countries. Cross-national variation in the gender gap in depression. Soc Sci Med 71(2):305–313
Organization WH (2014) Integrating the response to mental in health care systems disorders and other chronic diseases in health care systems, vol 1. World Health Organization
Stewart D, Rondon M, Damiani G, Honikman J (2001) International psychosocial and systemic issues in women's mental health. Arch Womens Ment Health 4(1):13–17
Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349(9064):1498–1504. doi:10.1016/s0140-6736(96)07492-2
Sadeghirad B, Haghdoost A-A, Amin-Esmaeili M, Ananloo ES, Ghaeli P, Rahimi-Movaghar A, Talebian E, Pourkhandani A, Noorbala AA, Barooti E (2010) Epidemiology of major depressive disorder in Iran: a systematic review and meta-analysis. Int J Preventive Med 1(2):81
Richards D (2011) Prevalence and clinical course of depression: a review. Clin Psychol Rev 31(7):1117–1125
Saracli O, Akca AS, Atasoy N, Onder O, Senormanci O, Kaygisiz I, Atik L (2015) The relationship between quality of life and cognitive functions, anxiety and depression among hospitalized elderly patients. Clin Psychopharmacol Neurosci 13(2):194–200. doi:10.9758/cpn.2015.13.2.194
Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, Vos T, Whiteford HA (2013) Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010
Organization WH (2013) Mental health action plan 2013–2020, vol 1. World Health Organization, Geneva
Agarwal M, Hamilton JB, Moore CE, Crandell JL (2010) Predictors of depression among older African American cancer patients. Cancer Nurs 33(2):156–163. doi:10.1097/NCC.0b013e3181bdef76
Nicholson A, Kuper H, Hemingway H (2006) Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 27(23):2763–2774
Haenisch B, Bönisch H (2011) Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters. Pharmacol Ther 129(3):352–368
Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157(10):1552–1562
Jacka F, Berk M (2007) Food for thought. Acta Neuropsychiatrica. Acta Neuropsychiatrica 19(5):321–323. doi:10.1111/j.1601-5215.2007.00246.x
Eby GA, Eby KL (2010) Magnesium for treatment-resistant depression: a review and hypothesis. Med Hypotheses 74(4):649
Dong JY, Xun P, He K, Qin LQ (2011) Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 34(9):2116–2122. doi:10.2337/dc11-0518
Volpe SL (2015) Magnesium and the athlete. Curr Sports Med Rep 14(4):279–283
de Baaij JH, Hoenderop JG, Bindels RJ (2015) Magnesium in man: implications for health and disease. Physiol Rev 95(1):1–46. doi:10.1152/physrev.00012.2014
Boancă M, Popa EG, Lupuşoru R, Poroch V, Mititelu-Tarţău L, Lupuşoru CE (2014) The effects of magnesium nanovesicle formulations on spatial memory performance in mice. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 118(3):847–853
Barbagallo M, Dominguez LJ (2015) Magnesium and type 2 diabetes. World J Diabetes 6(10):1152–1157. doi:10.4239/wjd.v6.i10.1152
Derom M-L, Sayón-Orea C, Martínez-Ortega JM, Martínez-González MA (2012) Magnesium and depression: a systematic review. Nutritional neuroscience
Mori K, Yamamoto T, Nakao Y, Miyazaki M, Iwata J, Tamura M, Shiroishi T (2012) Novel neuroprotective effect of cisternal and intra-cerebral magnesium sulfate solution infusion on delayed cerebral death in rat hippocampal neurons after transient global ischemia. Brain Res 1480:72–80
Swaminathan R (2003) Magnesium metabolism and its disorders. Clin Biochem Rev 24(2):47
Poleszak E, Wlaź P, Kędzierska E, Nieoczym D, Wróbel A, Fidecka S, Pilc A, Nowak G (2007) NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice. Pharmacol Biochem Behav 88(2):158–164
Krystal JH, D'Souza DC, Petrakis IL, Belger A, Berman RM, Charney DS, Abi-Saab W, Madonick S (1999) NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harv Rev Psychiatry 7(3):125–143
Poleszak E, Wlaz P, Wrobel A, Dybala M, Sowa M, Fidecka S, Pilc A, Nowak G (2007) Activation of the NMDA/glutamate receptor complex antagonizes the NMDA antagonist-induced antidepressant-like effects in the forced swim test. Pharmacol Rep 59(5):595–600
Derom M-L, Martínez-González MA, del Carmen S-OM, Bes-Rastrollo M, Beunza JJ, Sánchez-Villegas A (2012) Magnesium intake is not related to depression risk in Spanish university graduates. J Nutr 142(6):1053–1059
Syedmoradi L, Ghasemi A, Zahediasl S, Azizi F (2011) Prevalence of hypo-and hypermagnesemia in an Iranian urban population. Ann Hum Biol 38(02):150–155
Dabson KS, Mohammadkhani P (2007) Psychometrics characteristic of Beck depression inventory-II in patients with major depressive disorder. J Rehabil 8(2):82–80
Association AP (2000) Diagnostic and statistical manual of mental disorders. 4th text revision ed. Washington, DC: American Psychiatric Association:553–557
Hermes Sales C, Azevedo Nascimento D, Queiroz Medeiros AC, Costa Lima K, Campos Pedrosa LF, Colli C (2014) There is chronic latent magnesium deficiency in apparently healthy university students. Nutr Hosp 30(1):200–204. doi:10.3305/nh.2014.30.1.7510
la Cruz-Góngora D, Gaona B, Villalpando S, Shamah-Levy T, Robledo R (2012) Anemia and iron, zinc, copper and magnesium deficiency in Mexican adolescents: National Health and Nutrition Survey 2006. Salud Publica Mex 54(2):135–145
Mataix J, Aranda P, López-Jurado M, Sánchez C, Planells E, Llopis J (2006) Factors influencing the intake and plasma levels of calcium, phosphorus and magnesium in southern Spain. Eur J Nutr 45(6):349–354
Cheungpasitporn W, Thongprayoon C, Qian Q Dysmagnesemia in hospitalized patients: prevalence and prognostic importance. In: Mayo Clinic Proceedings, 2015. Elsevier, pp 1001–1010
Sales CH, Nascimento DA, Medeiros ACQ, Lima KC, Pedrosa LC, Colli C (2014) There is chronic latent magnesium deficiency in apparently healthy university students. Nutr Hosp 30(1):200
Tarleton EK, Littenberg B (2015) Magnesium intake and depression in adults. J Am Board Fam Med 28(2):249–256
Bae YJ, Kim MH, Choi MK (2010) Analysis of magnesium contents in commonly consumed foods and evaluation of its daily intake in Korean independent-living subjects. Biol Trace Elem Res 135(1–3):182–199. doi:10.1007/s12011-009-8511-x
Chaudhary DP, Sharma R, Bansal DD (2010) Implications of magnesium deficiency in type 2 diabetes: a review. Biol Trace Elem Res 134(2):119–129
Kim T-H, Choi J-y, Lee H-H, Park Y (2015) Associations between dietary pattern and depression in Korean adolescent girls. Journal of Pediatric and Adolescent Gynecology
Rahe C, Baune BT, Unrath M, Arolt V, Wellmann J, Wersching H, Berger K (2015) Associations between depression subtypes, depression severity and diet quality: cross-sectional findings from the BiDirect Study. BMC psychiatry 15(1):38
Lee SP, Sung I-K, Kim JH, Lee S-Y, Park HS, Shim CS (2015) The effect of emotional stress and depression on the prevalence of digestive diseases. J Neurogastroenterol Motil 21(2):273
Elin RJ (2010) Assessment of magnesium status for diagnosis and therapy. Magnes Res 23(4):194–198
Weglicki WB (2012) Hypomagnesemia and inflammation: clinical and basic aspects. Annu Rev Nutr 32:55–71. doi:10.1146/annurev-nutr-071811-150656
Rodríguez-Ortiz ME, Canalejo A, Herencia C, Martínez-Moreno JM, Peralta-Ramírez A, Perez-Martinez P, Navarro-González JF, Rodríguez M, Peter M, Gundlach K (2014) Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration. Nephrol Dial Transplant 29(2):282–289
Cheungpasitporn W, Thongprayoon C, Mao M, Srivali N, Ungprasert P, Varothai N, Sanguankeo A, Kittanamongkolchai W, Erickson S (2015) Hypomagnesaemia linked to depression: a systematic review and meta‐analysis. Internal medicine journal 45(4):436–440
Whittle N, Li L, Chen W-Q, Yang J-W, Sartori SB, Lubec G, Singewald N (2011) Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior. Amino Acids 40(4):1231–1248
Jin D-Z, Xue B, Mao L-M, Wang JQ (2015) Metabotropic glutamate receptor 5 upregulates surface NMDA receptor expression in striatal neurons via CaMKII. Brain Res 1624:414–423
Acknowledgments
I would like to thank Shahid Sadoughi University of Medical Sciences for their continued attention and their financial support of this research. I also extend my thanks to the officials and employees of Khatam-ol-Anbiya Clinic, the central laboratory of Shahid Sadoughi University of Medical Sciences in Yazd, and all the participants whose close cooperation facilitated completion of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rajizadeh, A., Mozaffari-Khosravi, H., Yassini-Ardakani, M. et al. Serum Magnesium Status in Patients Subjects with Depression in the City of Yazd in Iran 2013–2014. Biol Trace Elem Res 171, 275–282 (2016). https://doi.org/10.1007/s12011-015-0542-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-015-0542-x